Description
CUDC-907 (Fimepinostat) is an inhibitor of PI3K and class I and II histone deacetylases (HDACs). This compound exhibits anticancer chemotherapeutic activity, inhibiting cell proliferation and tumor growth in a variety of cancer models.
Product Unit Size | Cost | Quantity | Stock |
---|
CUDC-907 (Fimepinostat) is an inhibitor of PI3K and class I and II histone deacetylases (HDACs). This compound exhibits anticancer chemotherapeutic activity, inhibiting cell proliferation and tumor growth in a variety of cancer models.
Cas No. | 1339928-25-4 |
---|---|
Purity | ≥98% |
Formula | C23H24N8O4S |
Formula Wt. | 508.55 |
Chemical Name | Fimepinostat |
IUPAC Name | N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide |
Synonym | Fimepinostat; CUDC 907; CUDC907 |
Solubility | DMSO 102 mg/mL (200.57 mM) Water Insoluble Ethanol Insoluble |
Appearance | White Crystal Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Qian C, Lai CJ, Bao R, et al. Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase activity and phosphatidylinositol 3-kinase signaling. Clin Cancer Res. 2012 Aug 1;18(15):4104-13. PMID: 22693356.
Marine toxin; actin polymerization inducer.
Bisphosphonate, chelating agent.
Indoleamine-2,3-dioxygenase inhibitor.
Macrolide; peptidyl transferase inhibitor, prot...
NSAID; COX-1/2 inhibitor.
Aminothiol, CoA component; ulcer inducer.
Pyrimidine nucleoside analog; DNA synthesis inh...
Anti-tuberculosis
Ansamycin; bacterial DNA-dependent RNA polymera...
Sulforaphane homolog, ITC found in cruciferous ...
Benzothiazepine; L-type Ca2+ channel blocker, p...
Statin; HMG-CoA reductase inhibitor, potential ...
Sulforaphane-cysteine conjugate.
Steroidal alkaloid found in Fritillaria; M2 mAC...
Tricyclic antidepressant; potential D1/2 antago...
Mycotoxin that has structural similarity to est...
Triazole; 14-α demethylase inhibitor, potentia...
Used to prevent chromium deficiency and to decr...
SERT and NET inhibitor, Nav1.7 Na+ channel bloc...
Dual kinase and GTPase inhibitor.